# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4613537 | F | Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
2. | ALA4613539 | F | Cytotoxicity against human ACHN cells assessed as reduction in cell viability after 72 hrs by MTT assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
3. | ALA4613540 | F | Cytotoxicity against human A172 cells assessed as reduction in cell viability after 72 hrs by MTT assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
4. | ALA4613541 | F | Cytotoxicity against human SK-MEL-3 cells assessed as reduction in cell viability after 72 hrs by MTT assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
5. | ALA4613542 | F | Cytotoxicity against human KB cells assessed as reduction in cell viability after 72 hrs by MTT assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
6. | ALA4613543 | F | Cytotoxicity against human A549 cells assessed as reduction in cell viability after 72 hrs by MTT assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
7. | ALA4613544 | F | Cytotoxicity against human A2780 cells assessed as reduction in cell viability after 72 hrs by MTT assay | Homo sapiens | 9 | cell-based format | Scientific Literature | ||
8. | ALA5244798 | F | Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 1 measured after 18 hrs by agar dilution method | Staphylococcus aureus | 5 | organism-based format | Scientific Literature | ||
9. | ALA5244799 | F | Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 measured after 18 hrs by agar dilution method | Staphylococcus aureus | 5 | organism-based format | Scientific Literature | ||
10. | ALA5244800 | F | Potency index, ratio of norfloxacin MIC to test compound MIC for antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 1 | Staphylococcus aureus | 3 | organism-based format | Scientific Literature | ||
11. | ALA5244801 | F | Potency index, ratio of norfloxacin MIC to test compound MIC for antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 | Staphylococcus aureus | 3 | organism-based format | Scientific Literature | ||
12. | ALA5244802 | F | Potency index, ratio of ciprofloxacin MIC to test compound MIC for antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 1 | Staphylococcus aureus | 3 | organism-based format | Scientific Literature | ||
13. | ALA5244803 | F | Potency index, ratio of ciprofloxacin MIC to test compound MIC for antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 | Staphylococcus aureus | 3 | organism-based format | Scientific Literature |